Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 3
2016 1
2017 1
2018 2
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean linglingpei (3 results)?
The NLS-Based Nonlinear Grey Multivariate Model for Forecasting Pollutant Emissions in China.
Pei LL, Li Q, Wang ZX. Pei LL, et al. Int J Environ Res Public Health. 2018 Mar 8;15(3):471. doi: 10.3390/ijerph15030471. Int J Environ Res Public Health. 2018. PMID: 29517985 Free PMC article.
Investigation of a Brownfield Conflict Considering the Strength of Preferences.
Yu J, Pei LL. Yu J, et al. Int J Environ Res Public Health. 2018 Feb 24;15(2):393. doi: 10.3390/ijerph15020393. Int J Environ Res Public Health. 2018. PMID: 29495314 Free PMC article.
An optimised grey buffer operator for forecasting the production and sales of new energy vehicles in China.
He LY, Pei LL, Yang YH. He LY, et al. Sci Total Environ. 2020 Feb 20;704:135321. doi: 10.1016/j.scitotenv.2019.135321. Epub 2019 Nov 18. Sci Total Environ. 2020. PMID: 31822407
Synthesis and antimycobacterial evaluation of natural oridonin and its enmein-type derivatives.
Xu S, Pei L, Li D, Yao H, Cai H, Yao H, Wu X, Xu J. Xu S, et al. Among authors: pei l. Fitoterapia. 2014 Dec;99:300-6. doi: 10.1016/j.fitote.2014.10.005. Epub 2014 Oct 12. Fitoterapia. 2014. PMID: 25316557
Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives.
Xu S, Li D, Pei L, Yao H, Wang C, Cai H, Yao H, Wu X, Xu J. Xu S, et al. Among authors: pei l. Bioorg Med Chem Lett. 2014 Jul 1;24(13):2811-4. doi: 10.1016/j.bmcl.2014.04.119. Epub 2014 May 9. Bioorg Med Chem Lett. 2014. PMID: 24835198
Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
Xu S, Yao H, Pei L, Hu M, Li D, Qiu Y, Wang G, Wu L, Yao H, Zhu Z, Xu J. Xu S, et al. Among authors: pei l. Eur J Med Chem. 2017 May 26;132:310-321. doi: 10.1016/j.ejmech.2017.03.055. Epub 2017 Mar 25. Eur J Med Chem. 2017. PMID: 28395199
Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S, Wang G, Lin Y, Zhang Y, Pei L, Yao H, Hu M, Qiu Y, Huang Z, Zhang Y, Xu J. Xu S, et al. Among authors: pei l. Bioorg Med Chem Lett. 2016 Jun 15;26(12):2795-2800. doi: 10.1016/j.bmcl.2016.04.068. Epub 2016 Apr 24. Bioorg Med Chem Lett. 2016. PMID: 27158140
Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates.
Xu S, Pei L, Wang C, Zhang YK, Li D, Yao H, Wu X, Chen ZS, Sun Y, Xu J. Xu S, et al. Among authors: pei l. ACS Med Chem Lett. 2014 May 28;5(7):797-802. doi: 10.1021/ml500141f. eCollection 2014 Jul 10. ACS Med Chem Lett. 2014. PMID: 25050168 Free PMC article.
Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.
Li D, Xu S, Cai H, Pei L, Zhang H, Wang L, Yao H, Wu X, Jiang J, Sun Y, Xu J. Li D, et al. Among authors: pei l. Eur J Med Chem. 2013 Jun;64:215-21. doi: 10.1016/j.ejmech.2013.04.012. Epub 2013 Apr 11. Eur J Med Chem. 2013. PMID: 23644204
Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents.
Li D, Xu S, Cai H, Pei L, Wang L, Wu X, Yao H, Jiang J, Sun Y, Xu J. Li D, et al. Among authors: pei l. ChemMedChem. 2013 May;8(5):812-8. doi: 10.1002/cmdc.201200559. Epub 2013 Mar 20. ChemMedChem. 2013. PMID: 23520191
Feedback